Dun & Bradstreet Launches D&B Healthcare Insights, Expanding Market Reach in Healthcare Sector
PorAinvest
viernes, 1 de agosto de 2025, 8:58 am ET1 min de lectura
DNB--
D&B Healthcare Insights integrates with D&B Hoovers' extensive database of over 320 million companies and 485 million contacts, combining it with healthcare-specific data covering more than 260,000 healthcare organizations. Users can access detailed information including facility profiles, operating room size, bed counts, procedure volumes, staffing numbers, and total visits. This healthcare dataset is the first in a series of new data offerings planned by Dun & Bradstreet for 2025 [1].
The platform's ability to provide specialized healthcare data sets it apart from generic business databases, allowing for more targeted sales and marketing strategies. Dun & Bradstreet's move into the healthcare sector addresses a common enterprise software challenge - how to extract more revenue from existing customers by offering high-value add-ons rather than relying solely on new customer acquisition [2].
The product architecture follows the proven SaaS playbook of modular design, offering the core D&B Hoovers platform with specialized data overlays that can be monetized as premium add-ons. This creates upsell opportunities within D&B's existing customer base while potentially attracting new clients specifically interested in healthcare intelligence [1].
Healthcare is just the first in a series of new, high-impact datasets Dun & Bradstreet plans to introduce this year, continuing to expand its data capabilities to serve the evolving needs of its clients and the industries they lead [2]. Dun & Bradstreet's new healthcare data product expands addressable market and strengthens its competitive position in the high-value healthcare vertical [1].
References:
[1] https://www.stocktitan.net/news/DNB/dun-bradstreet-unveils-d-b-healthcare-insights-to-help-sales-and-vkdsqe5al8yj.html
[2] https://www.prnewswire.com/news-releases/dun--bradstreet-unveils-db-healthcare-insights-to-help-sales-and-marketing-teams-across-industries-unlock-opportunities-in-the-healthcare-ecosystem-302517935.html
Dun & Bradstreet has launched D&B Healthcare Insights, a new dataset designed to enhance sales and marketing intelligence for companies targeting the healthcare sector. The platform integrates with D&B Hoovers and provides detailed information on healthcare organizations and healthcare providers, covering over 260,000 entities. This expansion into the healthcare sector is part of Dun & Bradstreet's plan to introduce new data offerings this year, aiming to create vertical-specific differentiation and command premium pricing.
Dun & Bradstreet (NYSE: DNB) has launched D&B Healthcare Insights, a comprehensive dataset designed to enhance sales and marketing intelligence for companies targeting the healthcare sector. The new solution, available as an add-on to D&B Hoovers, provides detailed information about healthcare organizations (HCOs) and healthcare providers (HCPs). This expansion into the healthcare sector is part of Dun & Bradstreet's plan to introduce new data offerings this year, aiming to create vertical-specific differentiation and command premium pricing.D&B Healthcare Insights integrates with D&B Hoovers' extensive database of over 320 million companies and 485 million contacts, combining it with healthcare-specific data covering more than 260,000 healthcare organizations. Users can access detailed information including facility profiles, operating room size, bed counts, procedure volumes, staffing numbers, and total visits. This healthcare dataset is the first in a series of new data offerings planned by Dun & Bradstreet for 2025 [1].
The platform's ability to provide specialized healthcare data sets it apart from generic business databases, allowing for more targeted sales and marketing strategies. Dun & Bradstreet's move into the healthcare sector addresses a common enterprise software challenge - how to extract more revenue from existing customers by offering high-value add-ons rather than relying solely on new customer acquisition [2].
The product architecture follows the proven SaaS playbook of modular design, offering the core D&B Hoovers platform with specialized data overlays that can be monetized as premium add-ons. This creates upsell opportunities within D&B's existing customer base while potentially attracting new clients specifically interested in healthcare intelligence [1].
Healthcare is just the first in a series of new, high-impact datasets Dun & Bradstreet plans to introduce this year, continuing to expand its data capabilities to serve the evolving needs of its clients and the industries they lead [2]. Dun & Bradstreet's new healthcare data product expands addressable market and strengthens its competitive position in the high-value healthcare vertical [1].
References:
[1] https://www.stocktitan.net/news/DNB/dun-bradstreet-unveils-d-b-healthcare-insights-to-help-sales-and-vkdsqe5al8yj.html
[2] https://www.prnewswire.com/news-releases/dun--bradstreet-unveils-db-healthcare-insights-to-help-sales-and-marketing-teams-across-industries-unlock-opportunities-in-the-healthcare-ecosystem-302517935.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios